Alert: New Earnings Report (7/31/24)-OncoGenex Pharmaceuticals Inc (NASDAQ: VRSK).
For its second fiscal quarter (ending June 30), OncoGenex Pharmaceuticals Inc (NASDAQ: VRSK) has reported E.P.S. of $2.16 compared to $1.41 a year ago. E.P.S. were $6.24 for the latest four quarters through June 30 […]